C
Andlauer Healthcare Group Inc. AND.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 1/12/2024Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 1/12/2024 due to an increase in the volatility index and total return index.
C
Hold 12/28/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C- from C on 12/28/2023 due to a decline in the total return index and volatility index.
C
Hold 12/13/2023Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 12/13/2023 due to an increase in the volatility index, growth index and solvency index. Debt to equity declined from 0.16 to 0.11, and operating cash flow increased 9.35% from $19.52M to $21.35M.
C
Hold 10/20/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C- from C on 10/20/2023 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from $0.2883 to $0.2754, EBIT declined 3.97% from $17.51M to $16.82M, and total revenue declined 3.85% from $121.82M to $117.14M.
C
Hold 7/27/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C from C+ on 7/27/2023 due to a noticeable decline in the volatility index and total return index.
C
Hold 6/8/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to C+ from B- on 6/8/2023 due to a major decline in the valuation index, growth index and volatility index. Operating cash flow declined 33.37% from $27.07M to $18.04M, earnings per share declined from $0.3462 to $0.2883, and EBIT declined 15.59% from $20.75M to $17.51M.
B
Buy 2/10/2023Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to B- from B on 2/10/2023 due to a noticeable decline in the total return index, growth index and volatility index. Earnings per share declined from $0.3839 to $0.3372, EBIT declined 9.62% from $23.62M to $21.35M, and total revenue declined 4.76% from $132.71M to $126.39M.
B
Buy 4/18/2022Downgrade
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to B from B+ on 4/18/2022 due to a major decline in the total return index, solvency index and volatility index.
B
Buy 3/28/2022Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B+ from B on 3/28/2022 due to a significant increase in the total return index and volatility index.
B
Buy 3/4/2022Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B from B- on 3/4/2022 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 335.76% from $9.67M to $42.15M, earnings per share increased from $0.246 to $1.0006, and total capital increased 54.26% from $273.46M to $421.84M.
B
Buy 11/3/2021Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to B- from C+ on 11/3/2021 due to a large increase in the total return index, growth index and efficiency index. Operating cash flow increased 18.93% from $13.28M to $15.8M, net income increased 15.85% from $9.17M to $10.63M, and total revenue increased 15.29% from $75.65M to $87.22M.
C
Hold 5/12/2021Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C+ from C on 5/12/2021 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 213.86% from $4.23M to $13.28M, total capital increased 62.37% from $175.55M to $285.03M, and EBIT increased 28.8% from $10.22M to $13.16M.
C
Hold 8/14/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C from C- on 8/14/2020 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 155.03% from $5.82M to $14.84M, the quick ratio increased from 1.33 to 1.69, and debt to equity declined from 0.68 to 0.6.
C
Hold 7/15/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to C- from E+ on 7/15/2020 due to an increase in the total return index.
E
Sell 6/2/2020Upgraded
Andlauer Healthcare Group Inc. (AND.TO) was upgraded to E+ from E on 6/2/2020 due to a large increase in the growth index, solvency index and valuation index. Earnings per share increased from $0.1428 to $0.162, debt to equity declined from 0.76 to 0.68, and EBIT increased 7.76% from $8.71M to $9.38M.
E
Sell 3/16/2020None
Andlauer Healthcare Group Inc. (AND.TO) was downgraded to E from U on 03/16/2020.
Weiss Ratings